A prospective open‐label trial of a <scp>CBD</scp>/<scp>THC</scp> cannabis oil in dravet syndrome

Abstract

TIL-TC150 was safe and well tolerated in our subjects. TIL-TC150 treatment resulted in a reduction in seizure counts, spike index on EEG, and improved quality of life measures. This study provides safety and dosing information for THC-containing cannabinoid preparations.